These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34102154)

  • 41. Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).
    Akpek EK; Cassard SD; Dunlap K; Hahn S; Ramulu PY
    Trans Am Ophthalmol Soc; 2015; 113():T3. PubMed ID: 26538773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Boston Keratoprosthesis type 1 (KPro) without contact lens wearing in end-stage corneal disease: The APEC experience.
    De Wit-Carter G; Hernández-Chavarría C; Navarro-Naranjo PI; Manzanillo-Rosario C; Navarro-Saucedo R; García-Albisua AM; Hernandez-Quintela E; Cabrera-Martínez E; Ordoñez-Ranz G; Sanchez-Huerta V
    Eur J Ophthalmol; 2024 Jul; 34(4):1063-1070. PubMed ID: 38099653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Posterior Segment Complications and Impact on Long-Term Visual Outcomes in Eyes With a Type 1 Boston Keratoprosthesis.
    Moshiri A; Safi M; Morse LS; Tang VD; Yiu G; Park SS; Schwab I; Li J; Mannis MJ
    Cornea; 2019 Sep; 38(9):1111-1116. PubMed ID: 31232746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Boston type 1 keratoprosthesis: the New York Eye and Ear experience.
    Patel AP; Wu EI; Ritterband DC; Seedor JA
    Eye (Lond); 2012 Mar; 26(3):418-25. PubMed ID: 22173079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes and complications of Boston keratoprosthesis type I implantation in unilateral versus bilateral corneal blindness.
    Touma S; Harissi-Dagher M
    Can J Ophthalmol; 2021 Apr; 56(2):130-136. PubMed ID: 33002416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ten-Year Outcome of Boston Type I Keratoprosthesis Surgery at a Tertiary Care Center.
    Tsou BC; Koseoglu ND; Akpek EK; Liu TYA
    Cornea; 2024 Aug; 43(8):982-988. PubMed ID: 38305331
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Aurolab Keratoprosthesis (KPro) versus the Boston Type I Kpro: 5-year Clinical Outcomes in 134 Cases of Bilateral Corneal Blindness.
    Basu S; Serna-Ojeda JC; Senthil S; Pappuru RR; Bagga B; Sangwan V
    Am J Ophthalmol; 2019 Sep; 205():175-183. PubMed ID: 30905723
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predictive factors of Boston Type I Keratoprosthesis outcomes: A long-term analysis.
    Kanu LN; Niparugs M; Nonpassopon M; Karas FI; de la Cruz JM; Cortina MS
    Ocul Surf; 2020 Oct; 18(4):613-619. PubMed ID: 32702418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. International results with the Boston type I keratoprosthesis.
    Aldave AJ; Sangwan VS; Basu S; Basak SK; Hovakimyan A; Gevorgyan O; Kharashi SA; Jindan MA; Tandon R; Mascarenhas J; Malyugin B; Padilla MD; Maskati Q; Agarwala N; Hutauruk J; Sharma M; Yu F
    Ophthalmology; 2012 Aug; 119(8):1530-8. PubMed ID: 22512986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes following Boston type 1 keratoprosthesis implantation in aniridia patients at the University of Montreal.
    Hassanaly SI; Talajic JC; Harissi-Dagher M
    Am J Ophthalmol; 2014 Aug; 158(2):270-276.e1. PubMed ID: 24844976
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Boston Type 1 Keratoprosthesis for Iridocorneal Endothelial Syndromes.
    Phillips DL; Goins KM; Greiner MA; Alward WL; Kwon YH; Wagoner MD
    Cornea; 2015 Nov; 34(11):1383-6. PubMed ID: 26398156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term outcomes following primary versus secondary Boston keratoprosthesis type 1 implantation.
    Nayman T; Bostan C; Szigiato AA; Harissi-Dagher M
    Br J Ophthalmol; 2022 Jul; 106(7):935-940. PubMed ID: 33622700
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of Boston keratoprosthesis implantation for failed keratoplasty after keratolimbal allograft.
    Hou JH; de la Cruz J; Djalilian AR
    Cornea; 2012 Dec; 31(12):1432-5. PubMed ID: 22236785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Boston keratoprosthesis type I in the elderly.
    Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
    Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes After Auro Keratoprosthesis Implantation: A Low-Cost Design Based on the Boston Keratoprosthesis.
    Venugopal A; Rathi H; Rengappa R; Ravindran M; Raman R
    Cornea; 2016 Oct; 35(10):1285-8. PubMed ID: 27429086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term visual acuity, retention and complications observed with the type-I and type-II Boston keratoprostheses in an Irish population.
    Duignan ES; Ní Dhubhghaill S; Malone C; Power W
    Br J Ophthalmol; 2016 Aug; 100(8):1093-7. PubMed ID: 26628625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intermediate-term Visual Outcomes and Complications of Type 1 Boston Keratoprosthesis With and Without Glaucoma Surgery.
    AlHilali S; Martinez-Osorio H; AlObaida I; Jomar D; AlZendi N; AlJassar F; AlShahwan S; Ahmad A; Malik R; Vargas J
    Cornea; 2022 Aug; 41(8):950-957. PubMed ID: 35184127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency.
    Shanbhag SS; Senthil S; Mohamed A; Basu S
    Br J Ophthalmol; 2021 Apr; 105(4):473-478. PubMed ID: 32554443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.